PubMed:10356629
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-24 | protein | denotes | Glucocorticoid receptors |
| T2 | 642-664 | cell_type | denotes | mononuclear leukocytes |
| T3 | 835-859 | protein | denotes | glucocorticoid receptors |
| T4 | 863-885 | cell_type | denotes | mononuclear leukocytes |
| T5 | 887-890 | cell_type | denotes | MNL |
| T6 | 1098-1121 | protein | denotes | glucocorticoid receptor |
| T7 | 1460-1463 | cell_type | denotes | MNL |
| T8 | 1841-1844 | cell_type | denotes | MNL |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-24 | protein_family_or_group | denotes | Glucocorticoid receptors |
| T2 | 94-110 | other_name | denotes | anorexia nervosa |
| T3 | 167-175 | lipid | denotes | cortisol |
| T4 | 201-209 | lipid | denotes | cortisol |
| T5 | 254-274 | other_organic_compound | denotes | metabolic substrates |
| T6 | 310-325 | lipid | denotes | glucocorticoids |
| T7 | 396-404 | multi_cell | denotes | patients |
| T8 | 429-445 | other_name | denotes | anorexia nervosa |
| T9 | 450-458 | multi_cell | denotes | patients |
| T10 | 464-488 | other_name | denotes | active Cushing's disease |
| T11 | 497-515 | multi_cell | denotes | healthy volunteers |
| T12 | 642-664 | cell_type | denotes | mononuclear leukocytes |
| T13 | 678-695 | lipid | denotes | [3H]dexamethasone |
| T14 | 722-735 | lipid | denotes | dexamethasone |
| T15 | 739-752 | nucleotide | denotes | [3H]thymidine |
| T16 | 835-859 | protein_family_or_group | denotes | glucocorticoid receptors |
| T17 | 863-885 | cell_type | denotes | mononuclear leukocytes |
| T18 | 887-890 | cell_type | denotes | MNL |
| T19 | 910-918 | multi_cell | denotes | patients |
| T20 | 924-940 | other_name | denotes | anorexia nervosa |
| T21 | 942-950 | multi_cell | denotes | patients |
| T22 | 956-980 | other_name | denotes | active Cushing's disease |
| T23 | 1098-1121 | protein_family_or_group | denotes | glucocorticoid receptor |
| T24 | 1162-1178 | other_name | denotes | anorexia nervosa |
| T25 | 1193-1202 | multi_cell | denotes | Cushing's |
| T26 | 1203-1211 | multi_cell | denotes | patients |
| T27 | 1224-1240 | multi_cell | denotes | control subjects |
| T28 | 1373-1394 | lipid | denotes | urinary free cortisol |
| T29 | 1413-1421 | multi_cell | denotes | patients |
| T30 | 1429-1442 | nucleotide | denotes | [3H]thymidine |
| T31 | 1460-1463 | cell_type | denotes | MNL |
| T32 | 1493-1509 | other_name | denotes | anorexia nervosa |
| T33 | 1524-1533 | multi_cell | denotes | Cushing's |
| T34 | 1534-1542 | multi_cell | denotes | patients |
| T35 | 1555-1571 | multi_cell | denotes | control subjects |
| T36 | 1605-1618 | lipid | denotes | dexamethasone |
| T37 | 1643-1659 | multi_cell | denotes | control subjects |
| T38 | 1663-1671 | multi_cell | denotes | patients |
| T39 | 1677-1693 | other_name | denotes | anorexia nervosa |
| T40 | 1743-1760 | other_name | denotes | Cushing's disease |
| T41 | 1765-1773 | multi_cell | denotes | patients |
| T42 | 1779-1795 | other_name | denotes | anorexia nervosa |
| T43 | 1818-1831 | nucleotide | denotes | [3H]thymidine |
| T44 | 1841-1844 | cell_type | denotes | MNL |
| T45 | 1875-1896 | lipid | denotes | urinary free cortisol |
| T46 | 1955-1974 | other_name | denotes | cushingoid features |
| T47 | 1978-1986 | multi_cell | denotes | patients |
| T48 | 1992-2008 | other_name | denotes | anorexia nervosa |
| T49 | 2055-2070 | lipid | denotes | glucocorticoids |
| T50 | 2112-2132 | other_organic_compound | denotes | metabolic substrates |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-67 | Sentence | denotes | Glucocorticoid receptors in anorexia nervosa and Cushing's disease. |
| S2 | 68-190 | Sentence | denotes | BACKGROUND: Patients with anorexia nervosa do not display cushingoid features in spite of elevated cortisol plasma levels. |
| S3 | 191-375 | Sentence | denotes | Whether a cortisol resistance or a reduced availability of the metabolic substrates necessary to develop the effect of glucocorticoids is responsible for this has not been established. |
| S4 | 376-584 | Sentence | denotes | METHODS: Twenty-two patients with severe restrictive anorexia nervosa, 10 patients with active Cushing's disease, and 24 healthy volunteers without psychiatric disorders or mood alterations were investigated. |
| S5 | 585-811 | Sentence | denotes | Glucocorticoid receptor characteristics were examined on mononuclear leukocytes by measuring [3H]dexamethasone binding and the effect of dexamethasone on [3H]thymidine incorporation, which represents an index of DNA synthesis. |
| S6 | 812-1085 | Sentence | denotes | RESULTS: The number of glucocorticoid receptors on mononuclear leukocytes (MNL) was comparable in patients with anorexia nervosa, patients with active Cushing's disease, and normal subjects (binding capacity 3.3 +/- 0.23 vs. 3.7 +/- 0.30 and 3.5 +/- 0.20 fmol/10(6) cells). |
| S7 | 1086-1422 | Sentence | denotes | Conversely, glucocorticoid receptor affinity was significantly decreased in anorexia nervosa as well as in Cushing's patients compared to control subjects (dissociation constant 4.0 +/- 0.31 and 4.1 +/- 0.34 vs. 2.9 +/- 0.29 nmol/L, p < .001) and inversely correlated with the levels of urinary free cortisol in both groups of patients. |
| S8 | 1423-1761 | Sentence | denotes | Basal [3H]thymidine incorporation in MNL was significantly reduced in anorexia nervosa as well as in Cushing's patients compared to control subjects (p < .001) and was diminished by dexamethasone to an extent similar to control subjects in patients with anorexia nervosa, but significantly (p < .001) less in those with Cushing's disease. |
| S9 | 1762-1904 | Sentence | denotes | In patients with anorexia nervosa, the incorporation of [3H]thymidine into the MNL was inversely correlated with urinary free cortisol levels. |
| S10 | 1905-2133 | Sentence | denotes | CONCLUSIONS: These data indicate that the lack of cushingoid features in patients with anorexia nervosa is not ascribable to a reduced sensitivity to glucocorticoids but is more likely due to the paucity of metabolic substrates. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 28-44 | NP | denotes | anorexia nervosa |
| C2 | 49-66 | NP | denotes | Cushing's disease |
| C4 | 94-110 | NP | denotes | anorexia nervosa |
| C3 | 80-110 | NP | denotes | Patients with anorexia nervosa |
| C5 | 126-145 | NP | denotes | cushingoid features |
| C6 | 250-274 | NP | denotes | the metabolic substrates |
| C7 | 310-325 | NP | denotes | glucocorticoids |
| C8 | 642-664 | NP | denotes | mononuclear leukocytes |
| C10 | 722-735 | NP | denotes | dexamethasone |
| C9 | 708-766 | NP | denotes | the effect of dexamethasone on [3H]thymidine incorporation |
| C11 | 768-773 | NP | denotes | which |
| C12 | 863-891 | NP | denotes | mononuclear leukocytes (MNL) |
| C14 | 924-940 | NP | denotes | anorexia nervosa |
| C13 | 910-940 | NP | denotes | patients with anorexia nervosa |
| C15 | 942-980 | NP | denotes | patients with active Cushing's disease |
| C16 | 986-1001 | NP | denotes | normal subjects |
| C17 | 1224-1240 | NP | denotes | control subjects |
| C18 | 1460-1463 | NP | denotes | MNL |
| C19 | 1555-1571 | NP | denotes | control subjects |
| C20 | 1605-1618 | NP | denotes | dexamethasone |
| C21 | 1643-1659 | NP | denotes | control subjects |
| C23 | 1663-1671 | NP | denotes | patients |
| C24 | 1677-1693 | NP | denotes | anorexia nervosa |
| C22 | 1663-1693 | NP | denotes | patients with anorexia nervosa |
| C26 | 1732-1737 | NP | denotes | those |
| C27 | 1743-1760 | NP | denotes | Cushing's disease |
| C25 | 1732-1760 | NP | denotes | those with Cushing's disease |
| C29 | 1779-1795 | NP | denotes | anorexia nervosa |
| C28 | 1765-1795 | NP | denotes | patients with anorexia nervosa |
| C30 | 1837-1844 | NP | denotes | the MNL |
| C31 | 1955-1974 | NP | denotes | cushingoid features |
| C33 | 1992-2008 | NP | denotes | anorexia nervosa |
| C32 | 1978-2008 | NP | denotes | patients with anorexia nervosa |
| C34 | 2055-2070 | NP | denotes | glucocorticoids |
| C35 | 2112-2132 | NP | denotes | metabolic substrates |
| R1 | C4 | C1 | coref-ident | anorexia nervosa,anorexia nervosa |
| R2 | C11 | C9 | coref-relat | which,the effect of dexamethasone on [3H]thymidine incorporation |
| R3 | C12 | C8 | coref-ident | mononuclear leukocytes (MNL),mononuclear leukocytes |
| R4 | C14 | C4 | coref-ident | anorexia nervosa,anorexia nervosa |
| R5 | C13 | C3 | coref-ident | patients with anorexia nervosa,Patients with anorexia nervosa |
| R6 | C17 | C16 | coref-ident | control subjects,normal subjects |
| R7 | C18 | C12 | coref-ident | MNL,mononuclear leukocytes (MNL) |
| R8 | C19 | C17 | coref-ident | control subjects,control subjects |
| R9 | C20 | C10 | coref-ident | dexamethasone,dexamethasone |
| R10 | C21 | C19 | coref-ident | control subjects,control subjects |
| R11 | C24 | C14 | coref-ident | anorexia nervosa,anorexia nervosa |
| R12 | C22 | C13 | coref-ident | patients with anorexia nervosa,patients with anorexia nervosa |
| R13 | C26 | C23 | coref-pron | those,patients |
| R14 | C27 | C2 | coref-ident | Cushing's disease,Cushing's disease |
| R15 | C25 | C15 | coref-ident | those with Cushing's disease,patients with active Cushing's disease |
| R16 | C29 | C24 | coref-ident | anorexia nervosa,anorexia nervosa |
| R17 | C28 | C22 | coref-ident | patients with anorexia nervosa,patients with anorexia nervosa |
| R18 | C30 | C18 | coref-ident | the MNL,MNL |
| R19 | C31 | C5 | coref-ident | cushingoid features,cushingoid features |
| R20 | C33 | C29 | coref-ident | anorexia nervosa,anorexia nervosa |
| R21 | C32 | C28 | coref-ident | patients with anorexia nervosa,patients with anorexia nervosa |
| R22 | C34 | C7 | coref-ident | glucocorticoids,glucocorticoids |
| R23 | C35 | C6 | coref-ident | metabolic substrates,the metabolic substrates |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 94-102 | HP_0002039 | denotes | anorexia |